[HTML][HTML] Highlights in Graft-vs-Host Disease From the 63rd American Society of Hematology Annual Meeting and Exposition
YB Chen - Clinical Advances in Hematology and …, 2022 - hematologyandoncology.net
Chronic graft-vs-host disease (GVHD) is a significant complication of hematopoietic cell
transplant (HCT), affecting more than 40% of patients. 1 The Janus kinase (JAK) 1/2 inhibitor …
transplant (HCT), affecting more than 40% of patients. 1 The Janus kinase (JAK) 1/2 inhibitor …